Companies: 10,795·Total market cap: $144.5T
Neuronetics, Inc.

Neuronetics, Inc.

STIMNASDAQHealthcare● Active
$1.31
+$0.02(+1.16%)
Market Cap$90812079
P/E Ratio
52W High$4.85
52W Low$0.8
SEC Filings

Neuronetics, Inc. (STIM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001227636 · STIM · NASDAQ · as of Jun 8, 2026

Filing snapshot

697
Total Filings
SD
Latest Form
2026-05-29
Most Recent
2018
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001227636 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-17
Fiscal Year End
Mar 17, 2026
Accession No.
0001104659-26-029004
Primary Document
stim-20251231x10k.htm
Source: data.sec.gov · CIK 0001227636 · Accession 0001104659-26-029004

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-05
8-KCurrent Report
8-K
2026-05-29Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-29
View
8-KCurrent Report
8-K
2026-05-29
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-27
View
8-KCurrent Report
8-K
2026-05-22
View
3Initial Statement of Beneficial Ownership
3
2026-05-13
View
10-QQuarterly Report
10-Q
2026-05-05
View
8-KCurrent Report
8-K
2026-05-05
View
EFFECTEFFECT
EFFECT
2026-04-10
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-09
View
DEF 14AProxy Statement
DEF 14A
2026-04-09
View
CORRESPCORRESP
CORRESP
2026-04-08
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-08
View
8-KCurrent Report
8-K
2026-04-06
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-03-31
View
3Initial Statement of Beneficial Ownership
3
2026-03-23
View
Showing 1–15 of 353 filingsForm 4 / 144 hidden· 697 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001227636  |  Exchange: NASDAQ · Healthcare

Neuronetics, Inc. (NASDAQ: STIM) has submitted 697 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001227636, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Neuronetics, Inc.'s most comprehensive regulatory disclosure. The most recent Neuronetics, Inc. 10-K was filed on 2026-03-17 for fiscal year ending 2026. Historical STIM 10-K annual reports are available from 2003 through 2026.

Investors researching Neuronetics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

STIM SEC Filings · 8 questions

Neuronetics, Inc. (STIM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 697 filings and access original documents at no cost. Neuronetics, Inc.'s CIK is 0001227636.

STIM SEC filingsNeuronetics, Inc. SEC documentsfind STIM 10-K